Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 7842362, 11 pages
http://dx.doi.org/10.1155/2016/7842362
Research Article

Electroacupuncture Alleviates Depressive-Like Symptoms and Modulates BDNF Signaling in 6-Hydroxydopamine Rats

1Departments of Neurobiology and Physiology, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Beijing Key Laboratory for Parkinson’s Disease, Beijing Institute for Brain Disorders, Capital Medical University, Beijing 100069, China
2Beijing Key Laboratory for Mental Disorders, China Clinical Research Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, 5 Ankang Alley, Beijing 100088, China

Received 10 April 2016; Accepted 16 June 2016

Academic Editor: Pierre Champy

Copyright © 2016 Min Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. S. Lima, E. F. Martins, A. M. Delattre et al., “Motor and non-motor features of Parkinson's disease—a review of clinical and experimental studies,” CNS and Neurological Disorders—Drug Targets, vol. 11, no. 4, pp. 439–449, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Seppi, D. Weintraub, M. Coelho et al., “The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease,” Movement Disorders, vol. 26, no. 3, pp. S42–S80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Papapetropoulos and D. C. Mash, “Psychotic symptoms in Parkinson's disease. From description to etiology,” Journal of Neurology, vol. 252, no. 7, pp. 753–764, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. A. M. Reijnders, U. Ehrt, W. E. J. Weber, D. Aarsland, and A. F. G. Leentjens, “A systematic review of prevalence studies of depression in Parkinson's disease,” Movement Disorders, vol. 23, no. 2, pp. 183–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. F. L. Rocha, M. G. R. Murad, B. P. Stumpf, C. Hara, and C. Fuzikawa, “Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis,” Journal of Psychopharmacology, vol. 27, no. 5, pp. 417–423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. F. J. E. Vajda and C. Solinas, “Current approaches to management of depression in Parkinson's disease,” Journal of Clinical Neuroscience, vol. 12, no. 7, pp. 739–743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. Shulman, X. Wen, W. J. Weiner et al., “Acupuncture therapy for the symptoms of Parkinson's disease,” Movement Disorders, vol. 17, no. 4, pp. 799–802, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. D. V. Arankalle and P. M. K. Nair, “Effect of electroacupuncture on function and quality of life in Parkinson's disease: a case report,” Acupuncture in Medicine, vol. 31, no. 2, pp. 235–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Xia, H.-D. Wang, Y. Ding, B. Kang, and W.-G. Liu, “Parkinson's disease combined with depression treated with electroacupuncture and medication and its effect on serum BDNF,” Zhongguo Zhen Jiu, vol. 32, no. 12, pp. 1071–1074, 2012. View at Google Scholar · View at Scopus
  10. F. Wang, L. Sun, X.-Z. Zhang et al., “Effect and potential mechanism of electroacupuncture add-on treatment in patients with Parkinson's disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 692795, 11 pages, 2015. View at Publisher · View at Google Scholar
  11. J. Jia, Z. Sun, B. Li et al., “Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats,” Behavioural Brain Research, vol. 205, no. 1, pp. 214–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Wang, Y. Pan, B. Xue et al., “The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease,” PLoS ONE, vol. 6, no. 5, Article ID e19790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Deng, E. Lv, J. Yang et al., “Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model,” Journal of Neuroinflammation, vol. 12, no. 1, article 103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. X.-Y. Liu, H.-F. Zhou, Y.-L. Pan et al., “Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats,” Experimental Neurology, vol. 189, no. 1, pp. 189–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. X.-B. Liang, X.-Y. Liu, F.-Q. Li et al., “Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy,” Molecular Brain Research, vol. 108, no. 1-2, pp. 51–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. W. Howells, M. J. Porritt, J. Y. F. Wong et al., “Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra,” Experimental Neurology, vol. 166, no. 1, pp. 127–135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Shimizu, K. Hashimoto, N. Okamura et al., “Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants,” Biological Psychiatry, vol. 54, no. 1, pp. 70–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Karege, G. Vaudan, M. Schwald, N. Perroud, and R. La Harpe, “Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs,” Molecular Brain Research, vol. 136, no. 1-2, pp. 29–37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Song, W. Che, W. Min-Wei, Y. Murakami, and K. Matsumoto, “Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress,” Pharmacology Biochemistry and Behavior, vol. 83, no. 2, pp. 186–193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Q.-Q. Mao, Z. Huang, X.-M. Zhong, Y.-F. Xian, and S.-P. Ip, “Brain-derived neurotrophic factor signalling mediates the antidepressant-like effect of piperine in chronically stressed mice,” Behavioural Brain Research, vol. 261, pp. 140–145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Smith, S. Makino, R. Kvetnansky, and R. M. Post, “Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus,” The Journal of Neuroscience, vol. 15, no. 3, pp. 1768–1777, 1995. View at Google Scholar · View at Scopus
  22. J. M. Bessa, M. Morais, F. Marques et al., “Stress-induced anhedonia is associated with hypertrophy of medium spiny neurons of the nucleus accumbens,” Translational Psychiatry, vol. 3, article e266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Castrén and T. Rantamäki, “The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity,” Developmental Neurobiology, vol. 70, no. 5, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. T. Tadaiesky, P. A. Dombrowski, C. P. Figueiredo, E. Cargnin-Ferreira, C. Da Cunha, and R. N. Takahashi, “Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease,” Neuroscience, vol. 156, no. 4, pp. 830–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Winter, A. Von Rumohr, A. Mundt et al., “Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats,” Behavioural Brain Research, vol. 184, no. 2, pp. 133–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. M. Santiago, J. Barbiero, R. W. Gradowski et al., “Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin,” Behavioural Brain Research, vol. 259, pp. 70–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Berghauzen-Maciejewska, J. Wardas, B. Kosmowska, U. Głowacka, K. Kuter, and K. Ossowska, “Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats,” PLoS ONE, vol. 10, no. 3, Article ID e0117698, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. L. L. Furlanetti, V. A. Coenen, and M. D. Döbrössy, “Ventral tegmental area dopaminergic lesion-induced depressive phenotype in the rat is reversed by deep brain stimulation of the medial forebrain bundle,” Behavioural Brain Research, vol. 299, pp. 132–140, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Carvalho, F. L. Campos, B. Coimbra et al., “Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits,” Molecular Neurodegeneration, vol. 8, no. 1, article 14, pp. 1–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. L. L. Furlanetti, V. A. Coenen, I. A. Aranda, and M. D. Döbrössy, “Chronic deep brain stimulation of the medial forebrain bundle reverses depressive-like behavior in a hemiparkinsonian rodent model,” Experimental Brain Research, vol. 233, no. 11, pp. 3073–3085, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Remy, M. Doder, A. Lees, N. Turjanski, and D. Brooks, “Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system,” Brain, vol. 128, no. 6, pp. 1314–1322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Yang, Y. Pei, Y.-L. Pan et al., “Enhanced antidepressant-like effects of electroacupuncture combined with citalopram in a rat model of depression,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 107380, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Yu, K. Wang, J. Deng et al., “Electroacupuncture produces the sustained motor improvement in 6-hydroxydopamine-lesioned mice,” PLoS ONE, vol. 11, no. 2, Article ID e0149111, 2016. View at Publisher · View at Google Scholar
  34. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger, “Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations,” Journal of the Neurological Sciences, vol. 20, no. 4, pp. 415–455, 1973. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Dauer and S. Przedborski, “Parkinson's disease: mechanisms and models,” Neuron, vol. 39, no. 6, pp. 889–909, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Schrag, “Psychiatric aspects of Parkinson's disease: an update,” Journal of Neurology, vol. 251, no. 7, pp. 795–804, 2004. View at Google Scholar · View at Scopus
  37. B. Scatton, F. Javoy-Agid, L. Rouquier, B. Dubois, and Y. Agid, “Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease,” Brain Research, vol. 275, no. 2, pp. 321–328, 1983. View at Publisher · View at Google Scholar · View at Scopus
  38. T. K. S. Craft and A. C. Devries, “Role of IL-1 in poststroke depressive-like behavior in mice,” Biological Psychiatry, vol. 60, no. 8, pp. 812–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Lieberman, “Depression in Parkinson's disease—a review,” Acta Neurologica Scandinavica, vol. 113, no. 1, pp. 1–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Maisonnette, J. P. Huston, M. Brandao, and R. K. W. Schwarting, “Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra,” Experimental Brain Research, vol. 120, no. 3, pp. 273–282, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Miyoshi, S. Wietzikoski, M. Camplessei, R. Silveira, R. N. Takahashi, and C. Da Cunha, “Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions,” Brain Research Bulletin, vol. 58, no. 1, pp. 41–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. A. L. Coppell, Q. Pei, and T. S. C. Zetterström, “Bi-phasic change in BDNF gene expression following antidepressant drug treatment,” Neuropharmacology, vol. 44, no. 7, pp. 903–910, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. H.-J. Park, S. Lim, W.-S. Joo et al., “Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model,” Experimental Neurology, vol. 180, no. 1, pp. 93–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Krishnan, M.-H. Han, D. L. Graham et al., “Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions,” Cell, vol. 131, no. 2, pp. 391–404, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. O. Aydemir, A. Deveci, and F. Taneli, “The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 29, no. 2, pp. 261–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Gervasoni, J.-M. Aubry, G. Bondolfi et al., “Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode,” Neuropsychobiology, vol. 51, no. 4, pp. 234–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. Eisch, C. A. Bolaños, J. De Wit et al., “Brain-derived neurotrophic factor in the ventral midbrain–nucleus accumbens pathway: a role in depression,” Biological Psychiatry, vol. 54, no. 10, pp. 994–1005, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Knott, G. Stern, A. Kingsbury, A. A. Welcher, and G. P. Wilkin, “Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra,” Parkinsonism and Related Disorders, vol. 8, no. 5, pp. 329–341, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. S. R. W. Stott and R. A. Barker, “Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease,” European Journal of Neuroscience, vol. 39, no. 6, pp. 1042–1056, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Pierucci, V. Di Matteo, A. Benigno, G. Crescimanno, E. Esposito, and G. Di Giovanni, “The unilateral nigral lesion induces dramatic bilateral modification on rat brain monoamine neurochemistry,” Annals of the New York Academy of Sciences, vol. 1155, no. 1, pp. 316–323, 2009. View at Publisher · View at Google Scholar · View at Scopus